Page 2 - Inhalation Solution News Today

To expand Lupin's portfolio of inhalation products in the US

(RTTNews) - United Therapeutics Corp. (UTHR) said that it has prevailed in dry powder inhaler patent litigation with Liquidia Technologies. Unite...

03.08.2022 - United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared ...

Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...

Press release content from Accesswire. The AP news staff was not involved in its creation.

EQS-Ad-hoc: Polyphor AG / Key word: Study Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin 15-Dec-2021 / 07:15 CET/CEST Release of... | December 15, 2021

Investegate announcements from Polyphor AG, Study

GuruFocus Article or News written by ACCESSWIRE and the topic is about:

/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...

/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced an update on the U.S. Food and Drug Administration (FDA) review of the new drug...